Old drug, new trick: pentoxifylline may shield kidneys in ICU
NCT ID NCT07561801
First seen May 14, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study tested whether pentoxifylline, a drug used for blood flow issues, could prevent kidney damage caused by contrast dye in 70 ICU patients with chronic kidney disease. Participants received the drug before procedures like cardiac catheterization. Researchers tracked how many developed contrast-induced nephropathy, changes in kidney function, ICU stay length, and need for dialysis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRAST-INDUCED NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tanta University
Tanta, El-Gharbia, 31527, Egypt
Conditions
Explore the condition pages connected to this study.